The Neurovascular Devices Market is expanding as healthcare systems increasingly adopt minimally invasive approaches for treating stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular conditions. According to Market Research Future, the global market was valued at USD 5.17 billion in 2025 and is projected to grow from USD 5.56 billion in 2026 to USD 10.48 billion by 2035, registering a CAGR of 8.22% during 2026–2035.

Technological advancements are playing an important role in market development. Neurovascular stents, embolization devices, catheters, flow diverters, and neurothrombectomy systems are increasingly designed to support precise, catheter-based interventions. The expansion of mechanical thrombectomy indications is also creating additional opportunities for device manufacturers, particularly in acute ischemic stroke treatment. Market Research Future identifies neurothrombectomy devices as one of the fastest-growing product categories, with a projected 9.14% CAGR through 2035.

Hospitals remain the leading end-user segment because advanced neuro-interventional procedures generally require specialized infrastructure, imaging systems, and trained clinical teams. In 2025, hospitals accounted for approximately 63% of the market, while ambulatory surgical centers are emerging as a faster-growing channel as selected cerebrovascular procedures increasingly move toward outpatient settings.

North America currently represents the largest regional market, supported by established stroke centers, reimbursement availability, advanced healthcare infrastructure, and high procedure volumes. Meanwhile, Asia-Pacific is expected to experience strong growth as countries invest in stroke-ready hospitals, improve access to specialized neurological care, and increase awareness of minimally invasive treatment options.

The future of the Neurovascular Devices Market is likely to be shaped by artificial intelligence, robotic catheter navigation, advanced flow diverters, next-generation embolization technologies, and data-driven procedural platforms. As healthcare providers focus on faster intervention, improved patient outcomes, and less invasive treatment, continued innovation in neurovascular devices is expected to create significant opportunities for manufacturers and healthcare institutions worldwide.